- Home
- EWTX vs RSI Comparison
EWTX vs RSI Comparison
Compare EWTX & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- RSI
- Stock Information
- Founded
- EWTX 2017
- RSI 2012
- Country
- EWTX United States
- RSI United States
- Employees
- EWTX N/A
- RSI N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- RSI Services-Misc. Amusement & Recreation
- Sector
- EWTX Health Care
- RSI Consumer Discretionary
- Exchange
- EWTX Nasdaq
- RSI Nasdaq
- Market Cap
- EWTX 1.6B
- RSI 1.7B
- IPO Year
- EWTX 2021
- RSI N/A
- Fundamental
- Price
- EWTX $21.22
- RSI $17.38
- Analyst Decision
- EWTX Buy
- RSI Strong Buy
- Analyst Count
- EWTX 10
- RSI 9
- Target Price
- EWTX $36.90
- RSI $20.63
- AVG Volume (30 Days)
- EWTX 1.0M
- RSI 1.7M
- Earning Date
- EWTX 11-06-2025
- RSI 10-29-2025
- Dividend Yield
- EWTX N/A
- RSI N/A
- EPS Growth
- EWTX N/A
- RSI N/A
- EPS
- EWTX N/A
- RSI 0.32
- Revenue
- EWTX N/A
- RSI $1,063,702,000.00
- Revenue This Year
- EWTX N/A
- RSI $21.42
- Revenue Next Year
- EWTX N/A
- RSI $16.31
- P/E Ratio
- EWTX N/A
- RSI $54.44
- Revenue Growth
- EWTX N/A
- RSI 23.15
- 52 Week Low
- EWTX $10.60
- RSI $9.54
- 52 Week High
- EWTX $35.99
- RSI $22.65
- Technical
- Relative Strength Index (RSI)
- EWTX 74.48
- RSI 42.65
- Support Level
- EWTX $16.70
- RSI $17.18
- Resistance Level
- EWTX $18.26
- RSI $17.70
- Average True Range (ATR)
- EWTX 1.25
- RSI 0.64
- MACD
- EWTX 0.39
- RSI 0.03
- Stochastic Oscillator
- EWTX 93.28
- RSI 36.42
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.